These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Acquired resistance to the ALK inhibitor crizotinib in the absence of an ALK mutation. Costa DB; Kobayashi S J Thorac Oncol; 2012 Mar; 7(3):623-5. PubMed ID: 22334013 [No Abstract] [Full Text] [Related]
8. [Analysis of therapeutic efficacy in 49 patients with advanced non-small cell cancer treated with gefitinib]. Zhang PL; Chen L Zhonghua Zhong Liu Za Zhi; 2007 Aug; 29(8):635-6. PubMed ID: 18210890 [No Abstract] [Full Text] [Related]
9. Osteonecrosis of the humeral head in a patient with non-small cell lung cancer receiving bevacizumab. Koczywas M; Cristea MC J Thorac Oncol; 2011 Nov; 6(11):1960-1. PubMed ID: 22005475 [No Abstract] [Full Text] [Related]
10. Mind-body medicine: lessons from a patient. Rodriguez AO Curr Opin Obstet Gynecol; 2011 Feb; 23(1):1-2. PubMed ID: 21191270 [No Abstract] [Full Text] [Related]
11. Quality of life: it's never too late. Steer CB; Marx GM; Galani E; Harper PG; Khayat D J Clin Oncol; 2002 Jul; 20(13):2915-7. PubMed ID: 12089218 [No Abstract] [Full Text] [Related]
12. Is surgery for T4 non-small-cell lung cancer worthwhile? Pramesh CS; Mistry RC; Deshpande RK; Sharma S Ann Thorac Surg; 2004 Aug; 78(2):753; author reply 753-4. PubMed ID: 15276574 [No Abstract] [Full Text] [Related]
13. Quality-of-life assessment in trials of lung cancer. Singh N; Agarwal R; Aggarwal AN Lancet; 2007 Sep; 370(9591):933; author reply 933-4. PubMed ID: 17869629 [No Abstract] [Full Text] [Related]
14. Improvements in quality of life and disease-related symptoms in patients with advanced non-small cell lung cancer treated with gefitinib. Zhang XT; Li LY; Wang SL; Mu XL; Wang MZ; Song W Chin Med J (Engl); 2005 Oct; 118(19):1661-4. PubMed ID: 16232354 [No Abstract] [Full Text] [Related]
15. Unsteady balance: the constraints of informal care. Baider L J Pediatr Hematol Oncol; 2011 Oct; 33 Suppl 2():S108-11. PubMed ID: 21952565 [TBL] [Abstract][Full Text] [Related]
16. Setting goals to maintain hope. Von Roenn JH; von Gunten CF J Clin Oncol; 2003 Feb; 21(3):570-4. PubMed ID: 12560453 [No Abstract] [Full Text] [Related]
17. Patient preferences in choosing chemotherapy regimens for advanced non-small cell lung cancer. Dubey S; Brown RL; Esmond SL; Bowers BJ; Healy JM; Schiller JH J Support Oncol; 2005; 3(2):149-54. PubMed ID: 15796447 [TBL] [Abstract][Full Text] [Related]
18. Prognostic value of response to chemotherapy using ultrasound in lung cancer with metastatic liver involvement. Görg C; Schwerk WB; Wolf M; Havemann K Bildgebung; 1990; 57(3-4):70-3. PubMed ID: 1965423 [TBL] [Abstract][Full Text] [Related]
19. [Acute pancreatitis and obstructive jaundice secondary to metastases from lung cancer]. Belhassen-García M; Velasco-Tirado V; Carpio-Pérez A; Soler-Fernández MC; López-Bernús A; Pardo-Lledias J; Fuentes-Pardo L; Iglesias-Gómez A Gastroenterol Hepatol; 2009 Dec; 32(10):697-701. PubMed ID: 19800149 [TBL] [Abstract][Full Text] [Related]
20. Palliative chemotherapy for non-small cell lung cancer: a measured dose of reality. Kalemkerian GP J Support Oncol; 2007 Jan; 5(1):27-8. PubMed ID: 17265783 [No Abstract] [Full Text] [Related] [Next] [New Search]